Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367247 · ClinicalTrials.gov registry record · NA
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT03367247 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 121 participants.
The verdict
NCT03367247, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.
Interventions
- BEHAVIORAL BOLSTER
- OTHER Enhanced Discharge Planning (EDP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2018-04-24 |
| Est. Completion | 2023-07-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367247
The ClinicalTrials.gov registry entry for NCT03367247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BOLSTER is the first listed.
NCT03367247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03367247 about?
NCT03367247 is a clinical study titled "BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal". This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.
What is the current status of trial NCT03367247?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2018-04-24. Estimated completion is 2023-07-27.
What interventions are being tested in trial NCT03367247?
The interventions under investigation include: BOLSTER (BEHAVIORAL), Enhanced Discharge Planning (EDP) (OTHER).
Who is sponsoring clinical trial NCT03367247?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.